BSECompany Update18h ago · 31 Jul 2026, 03:19 pm
The Board Meeting to be held on 01/08/2026 has been revised to 07/08/2026 The Board Meeting to be held on 01/08/2026 has been revised to 07/08/2026
Vivanza Biosciences Ltd · 530057
✦ AI SummaryResults
Vivanza Biosciences Ltd has rescheduled its Board Meeting from August 1st to August 7th, 2026, to consider unaudited financial results and other items.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Vivanza Biosciences Ltd - 530057 - Update on board meeting
Attachments (1)
📄pdf
Download →
3d13668f-ab73-4b21-9cad-eb570a87ddd6.pdf
View document text
VIVANZA BIOSCIENCES LIMITED
Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054.
Phone: 079-26870953, email: info@vivanzabiosciences.com, website: www.vivanzabiosciences.com
CIN: L24105GJ1982PLC005057
Date: 31th July, 2026
Department of Corporate Services,
BSE Limited,
Ground Floor, P. J. Towers,
Dalal Street,
Mumbai – 400001,
Scrip Code: 530057 ISIN: INE984E01035
Subject: Intimation of rescheduling of the Board Meeting
Ref: Board Meeting Intimation Letter dated July 28th, 2026
Dear Sir/Madam,
With reference to our earlier letter dated July 28th, 2026 and Pursuant to Regulation 29, 30 and Regulation
33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that
a meeting of the Board of Directors of the Company is rescheduled to be held on Friday, August 07th, 2026,
(instead of Saturday, August 01st, 2026 as announced earlier) at the Registered Office of the Company to
consider and approve the following items:
1. Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the
Company for the Quarter ended on June 30, 2026;
2. Take note of the Notice of Disclosure of Interest and Intimation u/s 164 of the Companies Act, 2013
3. Take note of Declarations from Independent Directors U/S 149(7) of The Companies Act, 2013
4. Any other business with the permission of the chair;
As per Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
Intimation of the Board meeting would be made available on the website of the company at:
https://vivanzabiosciences.com/announcement/
Further, as already informed, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended
from time to time, and Company's Internal Code for Prohibition of Insider Trading ('Code'), the trading
window for dealing in the securities of the Company for the Directors/Officers & Key Managerial Personnel
and Designated Persons of the Company defined under the Code has already been closed till the expiry of 48
hours after the declaration of Audited Financial Results for the Quarter and Year ended 30th June, 2026.
We request you to take the same on record.
Thanking you
For Vivanza Biosciences Limited
JAYENDRA MEHTA
MANAGING DIRECTOR
DIN: 08210602